![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, December 04, 2015 8:09:05 AM
Like NW stated "OUR CONVICTION IN THE TECHNOLOGY AND EARLY CLINICAL DATA, SUPPORTED BY GLOBALLY LEADING ONCOLOGY CLINICIANS, IS THE PRINCIPAL FACTOR IN OUR INVESTMENT".
I will keep on buying NWBO even if it hits 50cents because I believe in the science. Linda has stated publically she want NWBO to be a power house in this new arena called immunotherapy and so far with the passing of each day it is becoming more and more clearer that statement might end up being a fact.(NW just stated the principal factor for his investment was the science and the fact that globally renowned oncology clinicians believe NWBO is on the right part). Remember we know what the check points can do (15- 25% of the patient with most indications), we have an idea about cart T and we just had a glimpse of DCVAX DIRECT METHOD B for all solid tumors and i repeat for all solid tumors (SMILE)
Big Pharma is scared shitless and would love to kill this small company. Their best argument is personalized medicine is cumbersome and expensive, Linda counters that argument by saying i can make it easier and cheaper just watch me. So far so good, we are witnessing history being made right before our eyes. We now know DC Vax L can manufacturer a lifetime supple for a patient in 7 days(something that took 3 month to do years ago)and Direct can be automated. The skeptics said the same thing about going to the moon and Tesla just recently, they were wrong and so will they with NWBO .. Stay thirsty my friends.. LONG NWBO, 35000K STRONG AND ADDING
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM
Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM